Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-08

Clinical Trial Update: Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing ursolic acid's effects on insulin sensitivity and metabolic syndrome; results available after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ursolic acid (ursolic acid)

Snippet

Sponsor: University of Guadalajara | Conditions: Metabolic Syndrome X | Phase 2 | Status: COMPLETED | Results posted: 2020-10-08